|
|
 |
|
|
||||||||||||||||||
|
||||||||||||||||||||
|
|
|
||||||||||||||||||
|
|
|
Richard Pearson
After attaining his PhD from the Interdisciplinary Research Centre (IRC) in Biomedical Materials, Queen Mary and Westfield College at the Institute of Orthopaedics, Royal National Orthopaedic Hospital, Richard joined the Tissue Engineering group (1998) to work on peripheral nerve regeneration. He is now a Senior Research Fellow within the Department of Accident and Orthopaedic Surgery in the QMC, Nottingham.
Robin Quirk
Rob attained his PhD within the Tissue Engineering Group in 2000. His research involved developing methods of introducing modifying species at the surfaces of conventional polymer materials in order to control their biological interactions. Rob is also a qualified pharmacist and is now the Managing Director of RegenTec.
Jo O’Reilly
Jo attained her PhD within the Tissue Engineering Group in 2001. Her research investigated the role of the phospholipid bilayer in controlling the precipitation of calcium phosphates on biomaterials. This research formed the basis for the long term aim of developing a novel coating for medical implants or injectable lipid based bone substitute coating that hardens in situ into a mineral-filled composite. Jo now works for Roche as a Technology Transfer Manager.
Ali Salem
Ali attained his PhD within the Tissue Engineering Group in 2002. His research involved developing a new porous scaffold that can be delivered by syringe into a tissue or cavity as a polymer and cell slurry, the slurry forms a scaffold by cross-linking of the polymer particles by a mechanism that does not interfere with cell function. RegenTec is developing this technology and Ali is now an Associate Professor at the University of Iowa, USA.
Sarah Quirk
Sarah attained her PhD within the Tissue Engineering Group in 2002. Her research focused on ways to modify biomaterial surfaces to make them attractive to mammalian cells only, limiting the risk of bacterial infection (a major cause of implant failure). She also developed a quick and simple method of assessing the extent of mammalian and bacterial cell adhesion in a mixed culture. Sarah is now a Senior Scientist working within the Early Pharmaceutics & Technology group for 3M Health Care. Her role is to investigate and conduct feasibility assessments on novel inhaled medicines and excipients. Sarah is also the European Transdermal Technical Leader for 3M Drug Delivery Systems.
Elizabeth Pearson
Elizabeth graduated from Lancaster University in 2000 with a BSc (Hons) in Biological Sciences with Biomedicine. She went on to attain an MSc in Applied Biomolecular Technology from the University of Nottingham in 2001. Elizabeth joined the School of Pharmacy in 2001 as a postgraduate researcher on a joint project, funded by the BBSRC, in the Tissue Engineering Group and in the Laboratory of Biophysics and Surface Analysis. Elizabeth is now writing her PhD thesis.
Lisa Riccalton-Banks
Lisa joined the Tissue Engineering group in 1999 and attained her PhD in 2002. Her research focused on the importance of cell-to-cell communication in the maintenance of hepatocyte function. She is now a Research Scientist for RegenTec.
Andrew Lewis
Andy joined the Tissue Engineering group in 1999 and attained his PhD in 2003. His work focused on ways of expanding a small population of liver cells to allow the engineering of liver tissue. He developed a flow cytometric method of analysing hepatocyte proliferation, allowing the pattern of hepatocyte growth to be studied, and compare it to that seen during regeneration. Andy is now a Research Scientist for Critical Pharmaceuticals.
Martin Whitaker
Martin attained his PhD within the Tissue Engineering Group in 2003. His research focused on generating porous polymer scaffolds using supercritical fluid technology and the incorporation and release of growth factors, and the incorporation of mammalian cells, in these scaffolds. Martin is now Managing Director for a new University spin-out company, Critical Pharmaceuticals.
Adele Horobin
Originally trained as a zoologist at Sheffield University, Adele successfully completed, with Distinction, an MSc in Applied Biomolecular Technology at Nottingham University in 2000. Adele commenced a PhD within the Tissue Engineering Group in October 2000 investigating the practice of introducing greenbottle fly larvae (maggots) into chronic wounds, in order to aid healing. Adele is currently employed as a postdoctoral scientist within the School of Pharmacy.
Jennifer Unsworth
Jennifer has a BSc (Hons) in Medical Materials Science from the University of Nottingham. She joined the
Tissue Engineering Group in 2000 to study for a PhD funded by a Foresight LINK grant.
Jennifer investigated the influence of spatially organising chondrocytes within scaffolds on the properties
of the subsequently engineered cartilage.
In 2004, she joined Smith & Nephew to work as a postdoctoral research scientist specialising in cell biology.
Jennifer has now returned to the University of Nottingham and is working as a Medici Fellow in the Schools
of Chemistry and Pharmacy.
George Tsourapas
George graduated from the University of Essex with a BSc in Biochemistry In 2000. He then joined the Tissue Engineering group in October 2000 as a post-graduate student. George’s research concentrated on combining the physical entrapment of PEG to PLA surfaces to repel proteins whilst making the surface attractive for cell adhesion by immobilising the pentapeptide, GRGDS.
Rena Bhandari
Rena attained a BSc in Medical Biochemistry (Birmingham) in 1980. She went on to study for an MSc in Neurochemistry at the Institute of Psychiatry, London University (1981). She graduated in 1988 with a PhD in Biochemistry from Charing Cross and Westminster Medical School. She worked within the Tissue Engineering Group from 1998-2004 on liver regeneration.
Katrina Teare
Katrina graduated in 1998 from the University of Manchester with a BSc (Hons) in Pharmacy. After spending a further year in Manchester studying for her professional qualification as a pharmacist, she worked for two years as a resident and cardiology pharmacist. She joined the Tissue Engineering Group in 2001 investigating the repair of spinal cord damage and attained her PhD in 2005.
Ian Wood
Ian attained a BPharm (Hons) (Nottingham) in Pharmacy in 1999 and was subsequently awarded MRPharmS registration in 2000. He is also currently an Associate of the College of Pharmacy Practice (ACPP). Ian joined the Tissue Engineering group in September 2001 researching methods of engineering neuromuscular junctions. Potential applications of this work include establishing an in vitro model for drug testing, muscle grafts, and development of bionic systems. Ian attained his PhD in 2005.
Yuxin Cui
Yuxin attained a BSc (Hons) in Biological Sciences (Harbin, China) in 1993 and subsequently an MPhil in Molecular Ecology (Shanghai, China) in 1999. He then worked in a medical university (Shanghai, China) as a scientific lecturer for two years, whilst researching the therapeutic mechanisms of leukaemia at both cellular and molecular levels. In 2001, he was invited as an academic visitor (Belfast, UK) to research in orthopaedics and trauma. Yuxin commenced an EPSRC funded PhD within the Tissue Engineering Group in April 2002 investigating the regeneration of pancreatic insulin-producing ß-cells. He gained his PhD in 2005 and is now a postdoctoral researcher within the Department of Physiology, Development and Neurosciences at the University of Cambridge.
Marta Silva
Marta graduated in Applied Chemistry (Biotechnology field) at the New University of Lisbon in 2001. She joined the Tissue Engineering Group in 2002 jointly supervised by Professors Kevin Shakesheff and Steve Howdle to design scaffolds with anisotropic architecture using supercritical technologies for cartilage engineering. Marta is now a Project Scientist at the National Institute for Biological Standards and Control in Hertfordshire, UK.
Paul De Bank
Paul attained a BSc (Hons) degree in Biochemistry and Biological Chemistry and a PhD from the University of Nottingham.
He joined the Tissue Engineering Group in 2000 to work on the engineering of neuromuscular junctions and more recently
was part of a successful bid funded by the EPSRC Adventure Fund which aims to use cell surface engineering strategies
to actively promote cell-cell interactions in order to form multicellular tissue-like structures.
Paul has recently taken up a lectureship at the School of Pharmacy at the University of Bath.
Pauline Lee
Pauline attained a BSc (Hons) in Applied Biology in 1988. She has worked for a number of years in the pharmaceutical
industry and studied part-time for a PhD, graduating from the University of Wales College of Cardiff in 1999.
She joined the Tissue Engineering Group in 2003 to work on models of liver differentiated function.
Pauline is now Cluster Development Manager for Healthcare Technologies at Yorkshire Forward.
John Barry
John began his studies at University College Cork in biological/chemical sciences and transferred to the
University of Aberdeen where he obtained a BSc (Hons) in Physiology in 1997. John undertook a period of research
studying kidney inflammation before moving to Nottingham in 2000 to study for a PhD in chemistry/biomaterials.
He joined the Tissue Engineering Group in 2003 as a postdoctoral researcher and is now a research scientist at
Baxter Biosurgery R&D, Vienna.
Bahaa Mohammed Ali
Bahaa graduated from the School of Pharmacy, Al-Azhar University, Cairo, Egypt, with a BSc in Pharmaceutical Science in 1989. He went to work in As-Salam International Hospital, where he studied Hospital Pharmacy and Clinical Pharmacy in 1992. He studied for Masters degree in Transdermal Drug Delivery System at the School of Pharmacy, Al-Azhar University, Cairo, Egypt and graduated in 1998. He joined the Tissue Engineering Group in 2002 to study for a Ph.D researching cell aggregation and is now writing his thesis.